Use of nuclear myocardial perfusion imaging exams dropped sharply between 2006 and 2011, but substitute imaging studies haven’t increased.
Use of nuclear myocardial perfusion imaging (MPI) has decreased significantly, according to a recent study in JAMA.
Researchers from Kaiser Permanente Medical Center in San Francisco, Calif., examined trends of MPI use from 2000 to 2011. The researchers obtained data regarding patients, aged 30 years or older, who underwent MPI within the healthcare delivery system.
The findings showed that MPI was used for 302,506 patients at 19 facilities. The imaging use increased by a relative 41 percent from 2000 to 2006. However, from 2006 to 2011, MPI use dropped by a relative 51 percent. Use dropped by 58 percent among outpatients and 31 percent among inpatients and for patients under age 65.
When looking to see if other imaging tests increased as a result of the MPI decrease, the researchers found that use of cardiac CT did increase and could have accounted for 5 percent of the observed decline in overall MPI use if performed as a substitute.
“The substantial reduction in MPI use demonstrates the ability to reduce testing on a large scale with anticipated reductions in health care costs,” wrote authors Edward J. McNulty, MD, and colleagues.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.